Cambridge Investment Research Advisors Inc. Purchases Shares of 17,915 First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Cambridge Investment Research Advisors Inc. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 17,915 shares of the company’s stock, valued at approximately $491,000. Cambridge Investment Research Advisors Inc. owned approximately 1.16% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of FTXH. Jane Street Group LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the second quarter valued at approximately $397,000. Janney Montgomery Scott LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $249,000. Royal Bank of Canada acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $1,019,000. B. Riley Wealth Advisors Inc. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $474,000. Finally, Centaurus Financial Inc. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $112,000.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

NASDAQ:FTXH opened at $25.73 on Friday. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $23.87 and a one year high of $28.59. The company has a market cap of $32.16 million, a P/E ratio of 16.99 and a beta of 0.70. The firm’s fifty day moving average price is $26.54 and its two-hundred day moving average price is $26.39.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 31st. Shareholders of record on Monday, March 27th were issued a $0.10 dividend. The ex-dividend date of this dividend was Friday, March 24th. This represents a $0.40 annualized dividend and a dividend yield of 1.55%.

First Trust Nasdaq Pharmaceuticals ETF Profile

(Get Rating)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.